Farmak, in cooperation with transnational company LG Life Science, has brought cosmetic Avouge® biogel to the market.
Avouge® is a cosmetic preparation, used in aesthetic medicine and cosmetology, in manufacturing of which a unique technology of hyaluronic acid stabilization is practised. Due to this, Avouge® biogel has evident long-term aesthetic effect and facilitates deep skin moistening.
Olena Alekseeva, a product manager of Farmak’s dermatological group, says, “Due to the high concentration of hyaluronic acid and the use of LG Life Sciences proprietary HESH-technology, Avouge® biogel stays in the dermis for a long time, is fixed at the injection site, does not migrate to other tissues and maximizes the effective duration of the contouring procedures.
Avouge® biogel has quality and durability results comparable with the most famous cosmetic brands, and an affordable price makes contour correction procedures available for a wider range of patients.”
It is worth mentioning that Farmak’s portfolio already includes the hyaluronic acid medicines. They are: Syngyal®, widely used for arthropathy treatment, Hyaral® та Hyaral® Plus, used in ocular surgery.
Growth of the global economy and the related high business activity will lead to an increase in demand for business trips. This forecast has been published by the Global Business Travel Association (GBTA). According to The Uriadovy Kurier, pharmacists are the main business tourism consumers in Ukraine. Farmak follows the global trend Farmak comprehensively c...
JSC “Farmak” will launch Eco-School, the single educational Internet platform, based on methodological materials approved by the Ministry of Education and Science of Ukraine from the beginning of the academic year. Eco-School is about to cover the whole territory of Ukraine and is becoming online. Due to the new Internet platform launched by Farm...
At the end of June, the European database EudraGMDP has been replenished with new GMP certificates that were issued by the regulatory authority of Poland to JSC “Farmak” for 2 manufacturing sites and a new storage site put into operation in the beginning of 2019. The planned recertification of 2 manufacturing sites confirmed their compliance […]